About

Oregon's state society was among the country's first, and was originally formed as a patient advocacy group.

The purpose of OSMO shall be:

  • To promote the highest professional standards of Oncology in the state of Oregon;
  • To study, research and exchange information, experiences and ideas leading to improvement in Oncology.

In order to carry out these interests, some of the goals for the Society include:

  • Affect legislation and public policy relative to patient access to cancer care
  • Act as a resource on the "accepted medical practices" associated with cancer care
  • Provide a forum for education of our members on current technologies and their role as accepted medical practices
  • Provide communications to our members and others on issues affecting patient access to cancer care and the practice of oncology

Officers 2017-2019

  • James L. Gajewski, MD, MACP
    President 2017-2019
    Portland, OR
  • Lucy Langer, MD
    President Elect
  • Benjamin L. Cho, MD
    Immediate Past President
    Willamette Valley Cancer Institute
    Eugene, OR
  • David H. Regan, MD
    Secretary/Treasurer
    Compass Oncology
    Portland, OR

Board of Trustees 2017-2019

  • Anupama Kurup Acheson, MD
    Providence Oncology
    Portland, OR
  • Gerald Ahmann, MD
    Emeritus Hematology Oncology Associates
    Medford, OR
  • Holly Almond, MSN, FNP
    Samaritan Hematology & Oncology Consultants
  • Charles David Blanke, MD, FACP, FASCO
    SWOG
    Knight Cancer Institute and OHSU
    Portland, OR
  • Archie Bleyer, MD
    OHSU
    Portland, OR
  • Christopher Crum, PA_C
    Hematology Oncology Associates
    Medford, OR
  • David Hufnagel, DO
    Samaritan Hematology & Oncology Consultants
  • Mujahid Rizvi, MD, MPH, FACP
    Hematology Oncology Associates
  • John M. Strother, MD
    Hematology Oncology of Salem
    Salem, OR
  • Kevin W. H. Yee, MD
    OHSU
    Tualatin, OR and Beaverton, OR
  • Matthew Lonergan, MD
    Willamette Valley Cancer Institute
    Eugene, OR